Interleukin-2 in combination with R-CHOP in the treatment of B-cell non-Hodgkin's lymphomas

被引：0
|
作者：
Sachivko, N. [1 ]
Zhavrid, E. [1 ]
Baranau, Y. [1 ]
Petrovitch, S. [1 ]
Zhuravkin, I. [1 ]
机构：
[1] NN Alexandrov Natl Canc Ctr Belarus, Minsk, BELARUS
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71905-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：564 / 564
页数：1
相关论文
共 50 条
  • [1] Combination immunotherapy of indolent B-Cell non-Hodgkin's lymphoma (B-NHL) with R-CHOP regimen and recombinant interleukin-2 (rIL-2) "Roncoleukin®"
    Kalenik, O.
    Zhavrid, E. A.
    Sachivko, N. V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S852 - S852
  • [2] Prognostic influence of BCL-2 expression in diffuse large B-cell non-Hodgkin's lymphomas treated with the R-CHOP regimen
    Gaudio, F.
    Giordano, A.
    Perrone, T.
    de Risi, C.
    Guarini, A.
    Delia, M.
    Napoli, A.
    Ricco, R.
    Specchia, G.
    Liso, V.
    ANNALS OF ONCOLOGY, 2008, 19 : 217 - 217
  • [3] Treatment of aggressive B-cell lymphomas: R-CHOP or more?
    Pfreundschuh, M.
    Oncology Research and Treatment, 2015, 38 : 108 - 108
  • [4] Primary Bone Marrow B-cell Non-Hodgkin's Lymphoma Successfully Treated with R-CHOP
    Qian, Liren
    Zhang, Zhi
    Shen, Jianliang
    Liu, Yi
    WEST INDIAN MEDICAL JOURNAL, 2013, 62 (01): : 89 - 91
  • [5] Maintenance Rituximab Following R-CHOP Chemotherapy in Patients with Composite or Discordant, Indolent and Aggressive, B-Cell Non-Hodgkin Lymphomas
    Kansara, Roopesh R.
    Connors, Joseph M.
    Savage, Kerry J.
    Scott, David W.
    Gascoyne, Randy D.
    Gerrie, Alina S.
    Sehn, Laurie H.
    Villa, Diego
    BLOOD, 2015, 126 (23)
  • [6] A phase III trial comparing R-CHOP 14 and R-CHOP 21 for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin's lymphoma
    Cunningham, D.
    Smith, P.
    Mouncey, P.
    Qian, W.
    Pocock, C.
    Ardeshna, K. M.
    Radford, J.
    Davies, J.
    McMillan, A.
    Linch, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] USE OF R-CHOP REGIMEN IN PATIENTS WITH B-CELL VIRUS ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL)
    Imamov, A.
    Abdiganieva, R.
    Pulatov, A.
    Abdurahmonov, A.
    Ibragimov, M.
    Tuydzhanova, K. H.
    Khakimov, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 43 - 43
  • [8] B-cell non-Hodgkin lymphomas
    Silkenstedt, Elisabeth
    Salles, Gilles
    Campo, Elias
    Dreyling, Martin
    LANCET, 2024, 403 (10438): : 1791 - 1807
  • [9] Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas
    Kansara, Roopesh
    Connors, Joseph M.
    Savage, Kerry J.
    Gerrie, Alina S.
    Scott, David W.
    Slack, Graham W.
    Gascoyne, Randy D.
    Sehn, Laurie H.
    Villa, Diego
    HAEMATOLOGICA, 2016, 101 (10) : E411 - E414
  • [10] Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: A preclinical and phase I study
    Eisenbeis, CF
    Grainger, A
    Fischer, B
    Baiocchi, RA
    Carrodeguas, L
    Roychowdhury, S
    Chen, L
    Banks, AL
    Davis, T
    Young, D
    Kelbick, N
    Stephens, J
    Byrd, JC
    Grever, MR
    Caligiuri, MA
    Porcu, P
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6101 - 6110
12345